Holen Sie sich die Stockscreener-App
1.05
4.98%
-0.055
Schlusskurs vom Vortag:
$1.105
Offen:
$1.14
24-Stunden-Volumen:
81,730
Relative Volume:
0.18
Marktkapitalisierung:
$23.34M
Einnahmen:
$411.00K
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-2.3864
EPS:
-0.44
Netto-Cashflow:
$-4.88M
1W Leistung:
-0.94%
1M Leistung:
+15.79%
6M Leistung:
+9.38%
1J Leistung:
-51.39%
1-Tages-Spanne:
$1.04
$1.14
1-Wochen-Bereich:
$0.9678
$1.19
52-Wochen-Spanne:
$0.7749
$2.8499
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Firmenname
Lexaria Bioscience Corp
Sektor
Branche
Telefon
250-765-6424
Adresse
100 - 740 MCCURDY ROAD, KELOWNA
Vergleichen Sie LEXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
1.05 | 24.56M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
S&P 500, NASDAQ and Dow rise as Wall Street ends volatile week on higher side: M-tron Industries gains nea - The Economic Times
What catalysts could drive Lexaria Bioscience Corp. stock higher2025 Momentum Check & Weekly Chart Analysis and Guides - newser.com
Will Lexaria Bioscience Corp. stock gain from lower inflationQuarterly Earnings Report & Fast Exit/Entry Strategy Plans - newser.com
Will Lexaria Bioscience Corp. Equity Warrant stock deliver long term returns2025 Market Trends & Verified Trade Idea Suggestions - newser.com
Key metrics from Lexaria Bioscience Corp.’s quarterly dataPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Lexaria Bioscience Corp. Equity Warrant stock sustain institutional interestMarket Movement Recap & AI Based Buy and Sell Signals - newser.com
Does Lexaria Bioscience Corp. stock trade at a discount to peers2025 AllTime Highs & Free Technical Confirmation Trade Alerts - newser.com
Is Lexaria Bioscience Corp. stock a top momentum playWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Lexaria Bioscience Corp. stock deliver consistent dividendsMarket Performance Recap & Expert Verified Movement Alerts - newser.com
Has Lexaria Bioscience Corp. found a price floorJuly 2025 Gainers & Technical Entry and Exit Tips - newser.com
How strong is Lexaria Bioscience Corp. Equity Warrant stock balance sheetJuly 2025 Market Mood & Weekly Breakout Stock Alerts - newser.com
Will Lexaria Bioscience Corp. stock maintain momentum in 2025Trade Analysis Report & Short-Term Trading Opportunity Alerts - newser.com
How to escape a deep drawdown in Lexaria Bioscience Corp. Equity WarrantMarket Risk Analysis & Reliable Price Action Trade Plans - newser.com
How to manage a losing position in Lexaria Bioscience Corp. Equity WarrantSell Signal & Daily Growth Stock Investment Tips - newser.com
How institutional buying supports Lexaria Bioscience Corp. stockAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Is Lexaria Bioscience Corp. Equity Warrant stock attractive for passive investors - newser.com
What makes Lexaria Bioscience Corp. Equity Warrant stock attractive to growth fundsBull Run & Risk Managed Trade Strategies - newser.com
Analyzing Lexaria Bioscience Corp. Equity Warrant with risk reward ratio chartsWeekly Risk Report & AI Powered Buy and Sell Recommendations - newser.com
How Lexaria Bioscience Corp. stock performs in rising dollar environment2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Chart overlay techniques for tracking Lexaria Bioscience Corp.Gap Up & Stepwise Entry and Exit Trade Signals - newser.com
Understanding Lexaria Bioscience Corp. Equity Warrant’s price movement2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Is Lexaria Bioscience Corp. forming a reversal patternMarket Trend Review & Smart Allocation Stock Reports - newser.com
Lexaria Extends Agreement to Advance Drug Delivery Technology Evaluation - MSN
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.38%
1.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):